Follow
Zeynep Safak Teksin
Zeynep Safak Teksin
Gazi University Faculty of Pharmacy
Verified email at gazi.edu.tr
Title
Cited by
Cited by
Year
Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen
ZS Teksin, IJ Lee, NN Nemieboka, AA Othman, VV Upreti, HE Hassan, ...
European Journal of Pharmaceutics and Biopharmaceutics 72 (2), 471-477, 2009
872009
Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach
A Karakucuk, N Celebi, ZS Teksin
European Journal of Pharmaceutical Sciences 95, 111-121, 2016
792016
Lipid composition effect on permeability across PAMPA
PR Seo, ZS Teksin, JPY Kao, JE Polli
European journal of pharmaceutical sciences 29 (3-4), 259-268, 2006
632006
Comparison of Drug Permeabilities and BCS Classification: Three Lipid-Component PAMPA System Method versus Caco-2 Monolayers
ZS Teksin, PR Seo, JE Polli
The AAPS journal 12, 238-241, 2010
592010
Evaluation of improved oral bioavailability of ritonavir nanosuspension
A Karakucuk, ZS Teksin, H Eroglu, N Celebi
European Journal of Pharmaceutical Sciences 131, 153-158, 2019
522019
Ion pair-mediated transport of metoprolol across a three lipid-component PAMPA system
ZS Teksin, K Hom, A Balakrishnan, JE Polli
Journal of controlled release 116 (1), 50-57, 2006
252006
Bioavailability of pentoxifylline-chitosan oral matrix tablet in healthy subjects
ZS Teksin, I Agabeyoglu, K Yamac
J Bioequiv Availab 1 (4), 115-120, 2009
242009
Formulation development, optimization by Box-Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self-nanoemulsifying drug delivery …
DY Usta, B Timur, ZS Teksin
European Journal of Pharmaceutical Sciences 174, 106159, 2022
232022
Bioavailability file: levofloxacin
D Sarisaltik, ZS Teksin
Fabad Journal of Pharmaceutical Sciences 32 (4), 197, 2007
222007
Development and validation of an HPLC method using an experimental design for analysis of amlodipine besylate and enalapril maleate in a fixed-dose combination
DS Yasin, AA Bingül, A Karaküçük, ZŞ Teksin
Turkish journal of pharmaceutical sciences 18 (3), 306, 2021
112021
Improved oral bioavailability of anticancer drug tamoxifen through complexation with water soluble cyclodextrins: in vitro and in vivo evaluation
N Erdoğar, E Nemutlu, AB İskit, SC Kara, ZŞ Teksin, E Bilensoy
Journal of Inclusion Phenomena and Macrocyclic Chemistry 96, 81-91, 2020
112020
Evaluation of in vitro dissolution characteristics of flurbiprofen, a BCS class IIa drug
DY Usta, Ö Demirtaş, C Ökçelik, A Uslu, ZŞ Teksin
FABAD Journal of Pharmaceutical Sciences 43 (2), 27-34, 2018
112018
Biyoeşdeğerlik Çalışmalarından Vazgeçilmesinde Biyofarmasötik İlaç Sınıflandırma Sistemlerinin Değerlendirilmesi: Biyofarmasötik Sınıflandırma Sistemi ve Biyofarmasötik İlaç …
D SARISALTIK, ZŞ TEKSİN
Journal of Literature Pharmacy Sciences 1 (1), 16-30, 2012
62012
The Development of SNEDDS Containing Bosentan Using Long Chain Mono and Diglyceride Mixtures
D YILMAZ USTA, Z TEKSİN
42018
Comparison of the hematological effects of a sustained release chitosan formulation of pentoxifylline with a commercial formulation
K Yamac, KM Kaptan, C Beyan, ZŞ Teksin, İT Ağabeyoğlu, L Gökgöz
Arzneimittelforschung 50 (09), 827-831, 2000
42000
Development and pharmacokinetic evaluation of Neusilin® US2-based S-SNEDDS tablets for bosentan: Fasted and fed states bioavailability, IVIS® real-time biodistribution, and ex …
DY Usta, S Olgac, B Timur, ZS Teksin
International Journal of Pharmaceutics 643, 123219, 2023
32023
Investigation of the effect of colloidal structures formed during lipolysis of lipid-based formulation on exemestane permeability using the in vitro lipolysis-permeation model
B Timur, DY Usta, ZS Teksin
Journal of Drug Delivery Science and Technology 77, 103797, 2022
32022
Evaluation of biorelevant media to investigate the dissolution properties on flurbiprofen and to assess cytotoxicity effects on Caco-2 cell line
DS YAŞIN, Ş YILMAZ, ZŞ Teksin
Istanbul Journal of Pharmacy 48 (3), 82-88, 2018
32018
In Vitro Çözünme Hizi Çalismalarinda Yeni Yaklasimlar/New approaches to in vitro dissolution rate studies
DY Usta, ZS Teksin
FABAD Journal of Pharmaceutical Sciences 40 (1), 33, 2015
32015
Nasal delivery of therapeutic agents using tight junction agonists
ND Eddington, KH Song, Z Teksin, AA Cross
US Patent App. 12/300,392, 2009
32009
The system can't perform the operation now. Try again later.
Articles 1–20